The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[5-(4-Indanylmethyl)thiazol-2-yl]-3-cyclohexanepropanamide ID: ALA4228008
PubChem CID: 145969104
Max Phase: Preclinical
Molecular Formula: C22H28N2OS
Molecular Weight: 368.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCC1CCCCC1)Nc1ncc(Cc2cccc3c2CCC3)s1
Standard InChI: InChI=1S/C22H28N2OS/c25-21(13-12-16-6-2-1-3-7-16)24-22-23-15-19(26-22)14-18-10-4-8-17-9-5-11-20(17)18/h4,8,10,15-16H,1-3,5-7,9,11-14H2,(H,23,24,25)
Standard InChI Key: XNRYWMUDNUDMSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
5.7445 -3.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3918 -3.5923 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.0674 -3.1324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8366 -2.3458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0206 -2.3255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8368 -3.4079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9828 -4.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7522 -4.4874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3596 -4.7404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9602 -3.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7667 -4.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3800 -5.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1676 -5.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3576 -4.6764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7888 -5.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9852 -4.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2919 -3.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6670 -4.4380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9742 -5.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8983 -5.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6676 -5.5669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8103 -6.3733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5756 -6.6495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2019 -6.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0576 -5.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2870 -5.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
1 10 1 0
10 11 1 0
11 16 2 0
15 12 2 0
12 13 1 0
13 14 2 0
14 11 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
8 20 1 0
20 21 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.55Molecular Weight (Monoisotopic): 368.1922AlogP: 5.52#Rotatable Bonds: 6Polar Surface Area: 41.99Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.05CX Basic pKa: 0.22CX LogP: 6.53CX LogD: 6.45Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -1.18
References 1. Ishita K, Stefanopoulos S, Khalil A, Cheng X, Tjarks W, Rappleye CA.. (2018) Synthesis and biological evaluation of aminothiazoles against Histoplasma capsulatum and Cryptococcus neoformans., 26 (9): [PMID:29580849 ] [10.1016/j.bmc.2018.01.024 ]